Add BrightSurf on Google Email

Chinese Medical Journals Publishing House Co., Ltd.


China’s experts outline a medical-preventive blueprint to tackle the resurgence of pertussis

China's experts have published a new consensus to tackle the resurgence of pertussis, driven by waning immunity and macrolide-resistant strains. The guidelines recommend a multi-faceted approach, including early identification, antimicrobial treatment, and life-course immunization strategies.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalInfectious Diseases & Immunity·TypeCommentary/editorial·DateOct 21, 2026

Hantavirus and the mouth: Review maps early oral warning signs, salivary clues, and precautions for dental teams

Hantavirus infections can be spread through saliva, causing early oral warning signs such as severe sore throats and swelling of the face, neck, and throat. Dental teams should be aware of the risks and take precautions, including referring patients promptly and avoiding aerosol-generating equipment.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalInfectious Diseases & Immunity·TypeLiterature review·DateOct 19, 2026

New review in Chinese Medical Journal illuminates the crosstalk between epigenetics and metabolism in hepatocellular carcinoma

Researchers systematically summarize how epigenetic modifications and metabolic reprogramming interact to drive hepatocellular carcinoma. The review highlights the epigenetic-metabolism axis as a promising therapeutic target and offers new insights for treatment.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeSystematic review·DateOct 16, 2026

Chinese Medical Journal article review synthesizes molecular mechanisms, current therapeutics, and emerging strategies in esophageal cancer

This comprehensive review synthesizes molecular mechanisms, current therapeutics, and emerging strategies in esophageal cancer. The findings highlight breakthroughs in immunotherapy and promising future directions in targeted therapies.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateOct 14, 2026

Recompensation may represent a new treatment-related state in cirrhosis

Researchers propose recognizing recompensation as a distinct treatment-related disease state, distinguishing stable and unstable recovery, to better capture recovery and continuing risks after cirrhosis treatment. This framework could support more consistent research, clinical assessment, and long-term surveillance for patients recover...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalPortal Hypertension & Cirrhosis·TypeLiterature review·DateOct 14, 2026

Chinese Medical Journal Published the Trends and Burden of Maternal Disorders from 1990 to 2023 in China

China's maternal disorder burden has declined significantly from 1990 to 2023, with substantial reductions in mortality and disability-adjusted life years. Despite progress, hypertensive disorders and indirect maternal deaths remain significant challenges, particularly among older pregnant women and those with chronic conditions.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateOct 13, 2026

Beyond recanalization: protecting the lungs in the era of stroke reperfusion therapy

Stroke-associated pneumonia remains a frequent obstacle to recovery after acute stroke, with various factors converging to shape pneumonia risk. The review highlights the importance of coordinated prevention and research priorities, including individualized treatment and emerging host-directed strategies.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateOct 12, 2026

Noninvasive coronary artery calcification assessment in people living with HIV: A call for integrated risk screening

Coronary artery calcification (CAC) progression is accelerated in people living with HIV due to chronic inflammation and immune activation. A new review proposes integrating CAC detection with biomarkers to identify individuals at highest risk for rapid CAC progression and future cardiovascular events.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalInfectious Diseases & Immunity·TypeLiterature review·DateOct 9, 2026

Chinese Medical Journal study reveals gallic acid inhibits prostate cancer progression via the NF-κB/KLF7/L1CAM Axis

Researchers discovered gallic acid suppresses tumor progression by targeting the NF-κB/KLF7/L1CAM axis in prostate cancer. The study demonstrated that gallic acid significantly impaired aggressive behaviors of PC-3 and LNCaP cells without toxicity to normal cells.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateOct 2, 2026

A new scale for reproductive aging in Chinese women based on ultra-sensitive AMH testing

A new scale for reproductive aging in Chinese women has been developed based on ultra-sensitive AMH testing. The scale provides age-specific percentiles for AMH levels in women aged 35-55, enabling earlier identification of women at risk of low ovarian reserve and better management of perimenopausal symptoms.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeObservational study·DateOct 1, 2026

Pancreatic cancer burden rises in both China and the US, but patterns diverge

A new study finds that high fasting glucose has surpassed tobacco use as the leading risk factor for pancreatic cancer in the US, while China faces a dual metabolic-tobacco burden. China recorded more absolute cases, but lower age-standardized rates, with a peak burden at ages 60-74.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalJournal of Pancreatology·TypeData/statistical analysis·DateSep 30, 2026

Exocrine pancreatic insufficiency affects 40% of chronic pancreatitis patients

A systematic review and meta-analysis found that approximately 40% of patients with chronic pancreatitis worldwide develop exocrine pancreatic insufficiency, a condition that can lead to malabsorption, weight loss, and deficiencies in fat-soluble vitamins. Smoking emerged as a significant modifiable risk factor, emphasizing the need fo...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalJournal of Pancreatology·TypeSystematic review·DateSep 28, 2026

Chinese Medical Journal evaluates triple regimen for HR+/HER2− advanced breast cancer

A phase Ib/II trial evaluated the triple combination of famitinib, dalpiciclib, and fulvestrant in HR+/HER2− breast cancer, meeting initial efficacy targets with a confirmed objective response rate of 51.9%. However, the regimen showed no superiority over standard first-line treatments and was terminated early due to safety concerns.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·DateSep 28, 2026

New review maps advances in coronary intravascular imaging and computational methods to support safer, personalized percutaneous coronary intervention for heart disease patients

Recent technical and computational improvements in coronary intravascular imaging can better characterize coronary lesions and identify high-risk plaques, improving outcomes for patients with coronary artery disease. The review highlights advances in imaging platforms, hybrid imaging systems, and artificial-intelligence approaches for ...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeLiterature review·DateSep 27, 2026

China reports real-world surgical outcomes for 6,297 pancreatic cancer patients

A Chinese registry report presents real-world perioperative and survival outcomes for surgically treated pancreatic cancer patients, achieving high overall survival rates and encouraging surgical safety metrics. The study emphasizes the need for national-level benchmarks and standardized clinical protocols for pancreatic surgery in China.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalJournal of Pancreatology·TypeData/statistical analysis·DateSep 25, 2026

Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance

Research evaluated ITGA3 expression across breast cancer subtypes and found its significance in prognosis and therapeutic relevance. High ITGA3 expression was associated with shorter recurrence-free survival and poorer clinical outcomes, making it a potential prognostic biomarker and therapeutic target.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCancer Pathogenesis and Therapy·TypeExperimental study·DateSep 10, 2026

Adjuvant immunotherapy shows no survival benefit for NSCLC patients achieving pCR after neoadjuvant treatment

A real-world observational study found no significant survival benefit from post-surgery immunotherapy in NSCLC patients with pathological complete response after neoadjuvant chemoimmunotherapy. The study suggests that these patients may already derive the maximum benefit from neoadjuvant therapy alone.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeObservational study·DateSep 2, 2026

Large, long-term study finds ANA positivity in Kikuchi-Fujimoto disease does not predict rheumatic disease

A large, long-term study of 140 patients with Kikuchi-Fujimoto disease found that ANA positivity is common but transient, with minimal risk of progression to lupus or other connective tissue diseases. The study's findings provide reassuring evidence that patients with KFD can be reassured of their excellent prognosis.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalRheumatology & Autoimmunity·TypeObservational study·DateSep 1, 2026

Rapid development of immunotherapy for gynecological tumors: How to achieve overtaking on the curve?

Immunotherapy for gynecological tumors offers durable responses and survival benefits, but complex immune evasion mechanisms and tumor microenvironment pose challenges. Current treatment options, such as ICIs and adoptive cell therapy, show promise, but precision immunotherapy is needed to improve patient outcomes.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateAug 31, 2026

Study finds that cognitive decline after omicron infection is largely reversible

A 2-year multicenter cohort study found that most hospitalized survivors maintained or regained cognitive function after Omicron infection, while older and reinfected patients may face progressive decline. The study identified age, infection history, and disease severity as risk factors for progressive decline.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeObservational study·DateAug 27, 2026

Prospective multicenter study of first-line stem cell mobilization with EAP regimen in multiple myeloma and lymphoma

A prospective multicenter study found the EAP regimen delivered outstanding mobilization effects, achieving 90.8% optimal mobilization in patients. The regimen showed good clinical tolerability, with most hematological toxicities well managed, and presented a practical alternative to conventional mobilization strategies.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeCommentary/editorial·DateAug 27, 2026

Chinese Medical Journal article: dietary tryptophan prevents sepsis via GPR37 activation

Researchers found that dietary tryptophan supplementation can prevent sepsis by enhancing macrophage bacterial defense through GPR37 activation, which increases phagocytic ability against bacteria. IPyA, a key metabolic product, directly binds to GPR37 on macrophages, activating RAC1/CDC42 and increasing phagocytosis.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateAug 26, 2026

Chinese Medical Journal reports RENI-1 findings on long-term niraparib effectiveness in ovarian cancer

The RENI-1 study found durable and clinically meaningful outcomes for niraparib maintenance therapy in ovarian cancer patients, with median PFS reaching 36.5 months. Long-term niraparib use was feasible, particularly in patients with BRCA1/2 mutations, and did not adversely affect quality of life.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeObservational study·DateAug 26, 2026

Meta analysis finds 87% 12 month freedom from atrial fibrillation with artificial intelligence enhanced catheter ablation for persistent atrial fibrillation

A systematic review and meta-analysis published in Cardiology Discovery shows AI-guided spatiotemporal dispersion area ablation yields an 87% pooled 12-month freedom-from-atrial-fibrillation rate for patients living with persistent atrial fibrillation. The technique aims to standardize substrate identification while preserving patient-...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeLiterature review·DateAug 25, 2026

The effect of plasminogen activator inhibitor-1 transcriptionally upregulated by c-terminal truncated hepatitis B virus X on the development of hepatocellular carcinoma

The study found that Ct-HBx upregulates PAI-1 by opening chromatin and trans-activating its expression, increasing hepatocellular carcinoma risk and prognosis. PAI-1 levels and genetic polymorphisms serve as biomarkers for predicting HCC risk and postoperative prognosis.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateAug 25, 2026

New blood test detects Alzheimer’s disease using plasma amyloid-β seeding activity

A new blood test detects Alzheimer's disease using plasma amyloid-β seeding activity, achieving a diagnostic accuracy exceeding 90% in the validation cohort. The test uses real-time ultrasonic protein misfolding cyclic amplification technology, marking a critical transition in AD diagnosis.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateAug 25, 2026

Single arm study finds dapagliflozin linked to 19% relative improvement in left ventricular ejection fraction among non diabetic Egyptian heart failure patients

A single-arm observational study found dapagliflozin improves left ventricular ejection fraction by 19% in non-diabetic Egyptian heart failure patients. The study demonstrated significant echocardiographic improvements and a low rate of mild short-term adverse events.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeObservational study·DateAug 24, 2026

National and regional lifetime risks of developing and dying from digestive system cancers in China: findings of the Global Burden of Disease Study 2023

Approximately 1 in 9 individuals in China will develop a digestive system cancer in their lifetime, with a staggering 1 in 12 succumbing to these diseases. The study reveals a profound 'risk transition' with colorectal cancer presenting the highest lifetime incidence risk.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateAug 24, 2026

Chinese Medical Journal article review explores tryptophan metabolism in female reproduction

This review explores the impact of tryptophan metabolism on female reproductive health, including ovarian function, fertility, and maternal-fetal health. It highlights the therapeutic potential of tryptophan metabolism in treating ovarian diseases and proposes dietary supplementation, modulation of the gut microbiota, and melatonin ant...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateAug 24, 2026

Delayed antiviral immune response in alveolar type 2 cells increases susceptibility to influenza virus in alveoli

Researchers found that alveolar type 2 cells mount slower interferon-driven antiviral defenses than type 1 cells, enabling higher viral replication in the alveoli. This study provides new insights into the primary site of influenza virus damage and opens up potential targets for antiviral therapy.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateAug 21, 2026

Prevalence, trends, and outcomes of pregnant women with PCOS in Chinese mainland

A large-scale study in China found the prevalence of PCOS among pregnant women increased from 0.79 to 19.0 per 10,000 between 2012 and 2021, with significantly higher risks of adverse maternal and neonatal outcomes. Women with PCOS had increased risks of diabetes, hypertension, preeclampsia, and cesarean delivery, as well as fetal risk...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeObservational study·DateAug 21, 2026

New clinical framework shifts coronary disease care away from vessel narrowing toward atherosclerotic plaque centered early intervention

A new clinical framework reorients coronary disease management toward early detection and stabilization of atherosclerotic plaques. The framework proposes a risk-stratified screening pathway for adults aged 40 or older with at least one traditional cardiac risk factor.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeCommentary/editorial·DateAug 20, 2026

Review outlines practical strategies to cut residual cardiovascular events for acute coronary syndrome survivors

A new review in Cardiology Discovery provides a structured clinical framework to identify and manage residual cardiovascular risks for patients surviving acute coronary syndrome. The framework groups risks into four categories and summarizes therapeutic options, emphasizing personalized risk re-evaluation for individual patients.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeLiterature review·DateAug 20, 2026

Review maps expanding treatment options for hypertrophic cardiomyopathy, an inherited leading cause of sudden cardiac death in young adults

A comprehensive review highlights recent progress and emerging therapies for hypertrophic cardiomyopathy, including cardiac myosin inhibitors, interventional techniques, and gene-based approaches. The treatment options now offer expanded pathways for both obstructive and non-obstructive patient subgroups, but limitations and uncertaint...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeLiterature review·DateAug 20, 2026

Perspective highlights real-world “risk-treatment-paradox”: highest-risk non-ST-elevation heart-attack patients often do not receive guideline-recommended early invasive care

A narrative perspective calls for multidimensional patient assessment beyond risk scores to address care disparities in non-ST-elevation myocardial infarction. Younger patients with ongoing ischemia may benefit from early angiography despite moderate risk scores.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalCardiology Discovery·TypeCommentary/editorial·DateAug 20, 2026

Chinese Medical Journal article review: Breaking through the dilemma of glioma treatment

Researchers review glioma microenvironment and related therapeutic strategies, highlighting the need to disrupt neuron-tumor communication and reprogram the immune landscape. This review provides a conceptual framework for next-generation therapies and marks a fundamental shift in glioma therapeutics.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateAug 20, 2026

The global burden of chronic kidney disease in women and its metabolic–cardiovascular links

The global burden of chronic kidney disease in women has grown, with 359 million cases in 2021, driving increasing mortality rates and disability-adjusted life years. Postmenopausal women and women of reproductive age are particularly vulnerable to metabolic and behavioral drivers that can be modified to reduce risk.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateAug 19, 2026

Circadian rhythms and sarcopenia: Unlocking the biological clock in muscle aging

Researchers reviewed the impact of circadian disruptions on muscle health, finding that imbalances in protein synthesis, mitochondrial function, and inflammation accelerate muscle deterioration. Circadian-aligned lifestyle interventions and pharmacological therapies, such as REV-ERBα agonists, hold promise for mitigating the effects of...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateAug 18, 2026

Study uncovers hidden immune remodeling in pneumocystis pneumonia, points to new therapeutic target

Researchers discovered a unique macrophage subset in pneumocystis pneumonia, which exhibited strong anti-inflammatory features and activated pro-proliferative pathways. Pharmacological inhibition of the MAPK pathway reversed this expansion, reducing immune suppression and paving the way for novel treatments.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalInfectious Diseases & Immunity·TypeExperimental study·DateAug 17, 2026

Epilepsy burden shifts as aging and health inequalities persist

The study found that epilepsy-associated disability-adjusted life years were concentrated in low- and lower-middle-income countries, with significant regional inequality. Progress has been made in China, including declining mortality rates, but challenges persist, particularly in rural areas where treatment gaps reach 60%–90%.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeLiterature review·DateAug 14, 2026

Mitochondrial matrix protein RTN4IP1 promotes the progression and metastasis of triple-negative breast cancer through metabolic reprogramming

The study identified RTN4IP1 as a factor associated with poor prognosis in triple-negative breast cancer, promoting metastasis through NAD⁺ depletion and disrupting glycolysis and oxidative phosphorylation. RTN4IP1 interacts with AK4 to cause this metabolic disruption.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateAug 12, 2026